F. Cheung

发表

Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.

T. Mok, S. Leung, W. Yeo, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.

Tae Min Kim, Ray Page, R. Motzer, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hong Kong Urological Association–Hong Kong Society of Uro‐Oncology consensus statements on the management of advanced prostate cancer—2019 Updates

D. Poon, F. Cheung, H. So, 2021, Asia-Pacific journal of clinical oncology.

Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.

T. Mok, S. Leung, W. Yeo, 2005, Journal of the National Cancer Institute.

Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally a

D. Kwong, A. Chan, A. Chan, 2015, Cancer.

Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro‐Oncology

D. Poon, F. Cheung, H. So, 2018, BJU international.

Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology

D. Poon, F. Cheung, H. So, 2021, Asia-Pacific journal of clinical oncology.

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

C. Law, R. Ngan, W. Lau, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

R. Motzer, K. Pittman, C. Barrios, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Ethnic Pharmacogenomic Differences in the Management of Asian Patients with Metastatic Prostate Cancer

H. Sze, D. Lam, Conrad Lee, 2022, Cancers.

Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

B. Zee, Conrad Lee, F. Cheung, 2016, American journal of clinical oncology.

Revisiting the role of bone‐modifying agents in the management of metastatic prostate cancer

F. Cheung, 2018, Asia-Pacific journal of clinical oncology.

Cutaneous indeterminate dendritic cell tumor with a protracted relapsing clinical course.

J. Chan, F. Cheung, K. Lee, 2009, The American journal of surgical pathology.

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

R. Motzer, K. Pittman, C. Barrios, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer.

R. Ngan, F. Cheung, K. C. Leung, 2013, Hong Kong medical journal = Xianggang yi xue za zhi.

A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006.

F. Cheung, S. C. Law, O. Mang, 2011, Hong Kong medical journal = Xianggang yi xue za zhi.

Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology

D. Poon, F. Cheung, H. So, 2019, BJU international.

Risk factors and natural history of breast cancer in younger Chinese women.

W. Yeo, A. Chan, F. Cheung, 2014, World journal of clinical oncology.

Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons

K. Au, R. Ngan, F. Cheung, 2011, Radiation oncology.

Definitive radiotherapy for early stage glottic cancer by 6 MV photons

K. Au, J. Au, F. Cheung, 2012, Head & neck oncology.

Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma

T. Yau, R. Poon, S. Chan, 2015, Liver Cancer.

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

H. Sze, F. Cheung, Anne W. M. Lee, 2014, Oral oncology.

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT.

F. Cheung, Anne W. M. Lee, W. Ng, 2014, Oral oncology.

Treatment Outcomes of Primary Pulmonary Lymphoepithelioma-like Carcinoma: a Series of 22 Patients and Treatment Strategy Review

F. Cheung, W. Ng, I. Soong, 2013 .

Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors

D. Poon, F. Cheung, A. Leung, 2023, Drugs in context.

Consensus Statements on Precision Oncology in the China Greater Bay Area

S. Lam, T. Lam, J. Au, 2023, JCO precision oncology.

Final overall survival analysis for the RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (mRCC).

R. Motzer, K. Pittman, C. Barrios, 2015 .

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.

R. Motzer, K. Pittman, C. Barrios, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.